1. Home
  2. GOOD vs QURE Comparison

GOOD vs QURE Comparison

Compare GOOD & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOOD
  • QURE
  • Stock Information
  • Founded
  • GOOD 2003
  • QURE 1998
  • Country
  • GOOD United States
  • QURE Netherlands
  • Employees
  • GOOD N/A
  • QURE N/A
  • Industry
  • GOOD Real Estate Investment Trusts
  • QURE Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOOD Real Estate
  • QURE Health Care
  • Exchange
  • GOOD Nasdaq
  • QURE Nasdaq
  • Market Cap
  • GOOD 670.2M
  • QURE 725.4M
  • IPO Year
  • GOOD N/A
  • QURE 2007
  • Fundamental
  • Price
  • GOOD $13.21
  • QURE $13.92
  • Analyst Decision
  • GOOD Hold
  • QURE Strong Buy
  • Analyst Count
  • GOOD 1
  • QURE 10
  • Target Price
  • GOOD $15.00
  • QURE $36.90
  • AVG Volume (30 Days)
  • GOOD 398.6K
  • QURE 1.4M
  • Earning Date
  • GOOD 08-06-2025
  • QURE 07-29-2025
  • Dividend Yield
  • GOOD 9.07%
  • QURE N/A
  • EPS Growth
  • GOOD N/A
  • QURE N/A
  • EPS
  • GOOD 0.30
  • QURE N/A
  • Revenue
  • GOOD $151,168,000.00
  • QURE $14,337,000.00
  • Revenue This Year
  • GOOD $4.73
  • QURE N/A
  • Revenue Next Year
  • GOOD $2.84
  • QURE $278.91
  • P/E Ratio
  • GOOD $44.86
  • QURE N/A
  • Revenue Growth
  • GOOD 3.01
  • QURE N/A
  • 52 Week Low
  • GOOD $12.67
  • QURE $4.45
  • 52 Week High
  • GOOD $17.88
  • QURE $19.18
  • Technical
  • Relative Strength Index (RSI)
  • GOOD 29.82
  • QURE 42.84
  • Support Level
  • GOOD $13.31
  • QURE $12.33
  • Resistance Level
  • GOOD $13.69
  • QURE $16.29
  • Average True Range (ATR)
  • GOOD 0.26
  • QURE 1.09
  • MACD
  • GOOD -0.07
  • QURE -0.11
  • Stochastic Oscillator
  • GOOD 7.95
  • QURE 34.51

About GOOD Gladstone Commercial Corporation Real Estate Investment Trust

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: